Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Oncology Letters|June 29, 2012
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancerLyndsay V Rhodes, Syreeta L Tilghman, Stephen M Boue, et al.
Heliyon|April 28, 2023
Novel roles for HMGA2 isoforms in regulating oxidative stress and sensitizing to RSL3-Induced ferroptosis in prostate cancer cellsTaaliah Campbell, Ohuod Hawsawi, Veronica Henderson, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 19, 2017
Osteoinductive effects of glyceollins on adult mesenchymal stromal/stem cells from adipose tissue and bone marrowMarjorie E Bateman, Amy L Strong, Ryan S Hunter, et al.
European Journal of Medicinal Chemistry|June 12, 2017
Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studiesXiaojie Zhang, Shanchun Guo, Chengsheng Chen, et al.
Molecular Oncology|March 3, 2017
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52Jugal Bharat Joshi, Divya Patel, Derrick J Morton, et al.
Journal of Medicinal Chemistry|August 17, 2016
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)Jiawang Liu, Shilong Zheng, Victoria L Akerstrom, et al.
Oncotarget|February 23, 2018
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft modelsShanchun Guo, Changde Zhang, Melyssa Bratton, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 4, 2016
Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expressionFengkun Du, Yan Li, Wensheng Zhang, et al.
Tissue Engineering. Part A|July 7, 2012
A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cellsRyan W Bonvillain, Svitlana Danchuk, Deborah E Sullivan, et al.
Research Square|May 4, 2026
Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory PropertiesJohn Shuhan Wang, Sirajbir S Sodhi, Li-Chung Tsao, et al.
Pageof 14